Phanes China

Phanes Therapeutics, Inc., founded by Dr. Minghan Wang, former Vice President of Johnson & Johnson, is a biotechnology company focused on the research and development of novel antibody drugs for cancer and eye diseases, with an emphasis on large-molecule protein therapeutics. Headquartered in San Diego, USA, with additional locations in Zhangjiang, Shanghai, China, and Songshan Lake, Guangdong, China, Phanes aims to address unmet clinical treatment needs worldwide. Through in-depth research into biological mechanisms and disease-related targets, and leveraging its top-tier antibody discovery and process development platforms, Phanes' core R&D team has successfully developed a series of innovative pipeline products, several of which are in the preparation stage for IND clinical trial applications. To date, Phanes has filed 17 patents and established two globally leading bispecific antibody technology platforms.